(Q43515187)

English

Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Oliver Pfaar

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

object named as

Ludger Klimek

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

256-263

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergen injection immunotherapy for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of near-fatal reactions to allergen immunotherapy injections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Position paper: Immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose dependence of immunological response to sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety profile of sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A two-site monoclonal antibody ELISA for the quantification of group V allergens in grass extracts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The CREATE project: EU support for the improvement of allergen standardization in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Noninjection routes for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of sublingual-swallow immunotherapy in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy in the treatment of children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Children's compliance with allergen immunotherapy according to administration routes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sublingual immunotherapy: update 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960451-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)60451-6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43515187&oldid=1990318641"